ATE530565T1 - Impfstoff zur prävention und behandlung von progressiver atrophischer rhinitis in schweinen - Google Patents

Impfstoff zur prävention und behandlung von progressiver atrophischer rhinitis in schweinen

Info

Publication number
ATE530565T1
ATE530565T1 AT05017940T AT05017940T ATE530565T1 AT E530565 T1 ATE530565 T1 AT E530565T1 AT 05017940 T AT05017940 T AT 05017940T AT 05017940 T AT05017940 T AT 05017940T AT E530565 T1 ATE530565 T1 AT E530565T1
Authority
AT
Austria
Prior art keywords
par
vaccine
pasteurella multocida
atrophic rhinitis
pigs
Prior art date
Application number
AT05017940T
Other languages
English (en)
Inventor
Maw-Sheng Chien
Cheng-I Liu
Chih-Ming Liao
Original Assignee
Nat Univ Chung Hsing
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nat Univ Chung Hsing filed Critical Nat Univ Chung Hsing
Application granted granted Critical
Publication of ATE530565T1 publication Critical patent/ATE530565T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/102—Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/285—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pasteurellaceae (F), e.g. Haemophilus influenza

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Mycology (AREA)
  • Communicable Diseases (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Otolaryngology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
AT05017940T 2004-08-20 2005-08-18 Impfstoff zur prävention und behandlung von progressiver atrophischer rhinitis in schweinen ATE530565T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CNA2004100575908A CN1736479A (zh) 2004-08-20 2004-08-20 猪进行性萎缩性鼻炎的预防、治疗与检测

Publications (1)

Publication Number Publication Date
ATE530565T1 true ATE530565T1 (de) 2011-11-15

Family

ID=36011175

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05017940T ATE530565T1 (de) 2004-08-20 2005-08-18 Impfstoff zur prävention und behandlung von progressiver atrophischer rhinitis in schweinen

Country Status (5)

Country Link
EP (1) EP1657248B1 (de)
CN (1) CN1736479A (de)
AT (1) ATE530565T1 (de)
DK (1) DK1657248T3 (de)
ES (1) ES2375280T3 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI285647B (en) * 2004-08-20 2007-08-21 Univ Nat Chunghsing Prevention, treatment and detection of porcine progressive atrophic rhinitis
EA201591861A1 (ru) * 2013-03-22 2016-03-31 Сбк Вирбак Лимитед Рекомбинантный токсин pasteurella multocida и его применение
CN107338208B (zh) * 2017-08-17 2020-07-28 天康生物股份有限公司 一种猪萎缩性鼻炎d型产毒多杀巴斯德氏菌疫苗株及其应用
CN109694401A (zh) * 2017-10-20 2019-04-30 金协国际实业有限公司 败血性巴氏杆菌毒素重组蛋白、其类病毒颗粒及其应用
TWI642681B (zh) * 2017-10-20 2018-12-01 金協國際實業有限公司 敗血性巴氏桿菌毒素重組蛋白、其類病毒顆粒及其應用
CN114230645A (zh) * 2022-01-12 2022-03-25 河南兴华生物技术有限公司 一种猪产毒多杀性巴氏杆菌的保护性抗原蛋白及其应用、疫苗
WO2025020119A1 (zh) * 2023-07-26 2025-01-30 安徽科技学院 一种猪萎缩性鼻炎灭活疫苗组合物的制备及应用方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK199588D0 (da) * 1988-04-12 1988-04-12 Nordisk Droge & Kemikalie Vaccine
DK120792D0 (da) * 1992-09-30 1992-09-30 Bioteknologisk Inst Protein

Also Published As

Publication number Publication date
EP1657248A2 (de) 2006-05-17
ES2375280T3 (es) 2012-02-28
EP1657248B1 (de) 2011-10-26
EP1657248A3 (de) 2006-05-24
CN1736479A (zh) 2006-02-22
DK1657248T3 (da) 2012-01-23

Similar Documents

Publication Publication Date Title
LU92262I2 (fr) Vaccin méningococcique groupe B (ADNr, composant, adsorbé) et ses dérivés pharmaceutiquement acceptables (BEXSERO)
ATE542829T1 (de) Impfstoff
RU2017123262A (ru) Иммуногенные композиции для применения в пневмококковых вакцинах
RU2007145052A (ru) Композиции пептидного конъюгата и способы для профилактики и лечения болезни альцгеймера
IL165605A0 (en) Molecular antigen arrays
CY1109492T1 (el) Ανοσογονες συνθεσεις βασιζομενες σε βιοδιασπωμενα μικροσωματιδια που περιλαμβανουν ανατοξινη διφθεριτιδας και ανατοξινη τετανου
BR0312792A (pt) Composições de vacinas contendo séries antigênicas de amilóide beta1-6
DE60329106D1 (de) Ghrelin-träger-konjugate
EA200701786A1 (ru) Поливалентная противогриппозная иммуногенная композиция
DK1534335T3 (da) FcgammaRIIB-specifikke antistoffer og fremgangsmåder til anvendelse deraf
SE0103754L (sv) Peptider från apolipoprotein B, användning därav immunisering, diagnosmetod eller terapeutisk behandling av ischemiska kardiovaskulära sjukdomar, samt farmaceutisk komposition och vaccin innehållande sådan peptid
PH12021552648A1 (en) Csfv subunit vaccine
TW200633719A (en) Glycoconjugate vaccines containing peptidoglycan
BRPI0607551A2 (pt) vacinas de combinação de helicobacter e circovìrus porcino e métodos de uso
ZA202107428B (en) Porcine circovirus type 3 (pcv3) vaccines, and production and uses thereof
EA202191145A1 (ru) Вакцина виб 4/91 с гетерологичным шиповидным белком
BR0213941A (pt) Arranjos de antìgeno para o tratamento de doença óssea
ECSP024257A (es) Proteinas antigenas del virus de la enfermedad de la mancha blanca en el camaron y usos de las mismas
ATE458496T1 (de) Hiv-vakzine und anwendungsverfahren
ATE530565T1 (de) Impfstoff zur prävention und behandlung von progressiver atrophischer rhinitis in schweinen
BR0207528A (pt) Anticorpo, composição farmacêutica, e, usos de uma quantidade efetiva de um agente, de uma quantidade terapeuticamente efetiva de um anticorpo para il-22, de uma quantidade imunogênica do antìgeno e uma quantidade aumentadora de imunogenicidade de il-22 em combinação, de uma quantidade efetiva do anticorpo ou fragmento do mesmo e de uma quantidade suficiente de anticorpo ou fragmento ligado a antìgeno do mesmo
CO6290771A2 (es) Composiciones y vacunas que comprenden una cantidad inmunogenica de una proteina o un fragmento e la misma que comprende una determinante antigenica de reactividad cruzada
TW200607812A (en) Prevention, treament and detection of porcine progressive atrophic rhinitis
DE60336063D1 (de) Verfahren, zusammensetzung und kit für die antigenbindung von norwalk-ähnlichen viren
MX2007002659A (es) Composicion vacunal contra el virus de la hepatitis c.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties